Lumbopelvic Stabilization Training Therapeutic for LBP

Share this content:
Lumbopelvic Stabilization Training Therapeutic for LBP
Lumbopelvic Stabilization Training Therapeutic for LBP

WEDNESDAY, Jan. 4, 2017 (HealthDay News) -- For patients with chronic nonspecific low back pain conditions, lumbopelvic stabilization training (LPST) has a therapeutic effect on pain modulation, according to a study published online Jan. 2 in Pain Practice.

Aatit Paungmali, Ph.D., from the Chiang Mai University in Thailand, and colleagues examined the effects of LPST on pain threshold and pain intensity compared with the passive automated cycling intervention and control intervention in a cohort of 25 patients with chronic nonspecific low back pain. Participants received all three types of experimental interventions randomly, with 48 hours between sessions.

The researchers found that LPST provided therapeutic effects, improving the pressure pain threshold significantly more than the placebo and control interventions. Under the LPST condition, the pain intensity was significantly better than under the passive automated cycling and control interventions. There was a significant trend of improvement beyond the control for heat pain threshold under the LPST condition, but no significant effects were seen for cold pain threshold.

"LPST may provide therapeutic effects by inducing pain modulation through an improvement in the pain threshold and reduction in pain intensity," the authors write. "LPST may be considered as part of the management programs for treatment of chronic low back pain."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »